We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$2.53B
AUM Growth
+$68.3M
Cap. Flow
+$49.5M
Cap. Flow %
1.96%
Top 10 Hldgs %
16.36%
Holding
1,009
New
121
Increased
515
Reduced
261
Closed
111

Top Sells

Rank Stock Value
1
OII icon
Oceaneering
OII
+$17.5M
2
ZBRA icon
Zebra Technologies
ZBRA
+$12.8M
3
ISRG icon
Intuitive Surgical
ISRG
+$11.2M
4
IPGP icon
IPG Photonics
IPGP
+$7.17M
5
IRBT
iRobot
IRBT
+$7.11M

Sector Composition

Rank Sector Weight
1 Technology 26.96%
2 Industrials 13.04%
3 Healthcare 11.78%
4 Consumer Discretionary 8.78%
5 Financials 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXP icon
676
American Express
AXP
$230B
$472K 0.02%
4,814
-666
-12% -$65.4K
PM icon
677
Philip Morris
PM
$295B
$472K 0.02%
5,842
+113
+2% +$9.59K
CDW icon
678
CDW
CDW
$17B
$471K 0.02%
5,833
-541
-8% -$41.9K
CNS icon
679
Cohen & Steers
CNS
$4.3B
$470K 0.02%
+11,258
New +$453K
LBRDA icon
680
Liberty Broadband Class A
LBRDA
$5.16B
$469K 0.02%
6,198
+1,212
+24% +$91.3K
NNN icon
681
NNN REIT
NNN
$8.99B
$466K 0.02%
10,601
-8,496
-44% -$343K
NVR icon
682
NVR
NVR
$17B
$466K 0.02%
157
+6
+4% +$18.4K
JBHT icon
683
JB Hunt Transport Services
JBHT
$25.2B
$464K 0.02%
3,825
-1,599
-29% -$196K
TSS
684
DELISTED
Total System Services, Inc.
TSS
$462K 0.02%
5,465
+214
+4% +$18.4K
BALL icon
685
Ball Corp
BALL
$16.8B
$460K 0.02%
12,939
+512
+4% +$19.6K
OHI icon
686
Omega Healthcare
OHI
$14.7B
$456K 0.02%
14,716
-13,039
-47% -$373K
ATHN
687
DELISTED
Athenahealth, Inc.
ATHN
$456K 0.02%
2,868
+32
+1% +$4.75K
SWX icon
688
Southwest Gas
SWX
$6.67B
$455K 0.02%
5,960
-432
-7% -$31.5K
NBIX icon
689
Neurocrine Biosciences
NBIX
$16.6B
$454K 0.02%
4,624
+52
+1% +$4.66K
TSM icon
690
TSMC
TSM
$2.18T
$454K 0.02%
+12,425
New +$491K
ZBH icon
691
Zimmer Biomet
ZBH
$18.4B
$451K 0.02%
4,165
-326
-7% -$35.5K
BPMC
692
DELISTED
Blueprint Medicines
BPMC
$449K 0.02%
7,077
+916
+15% +$72.9K
ADP icon
693
Automatic Data Processing
ADP
$108B
$447K 0.02%
+3,331
New +$422K
JACK icon
694
Jack in the Box
JACK
$335M
$447K 0.02%
5,253
+372
+8% +$32.1K
MNST icon
695
Monster Beverage
MNST
$88.5B
$445K 0.02%
15,516
-8,146
-34% -$220K
ARMK icon
696
Aramark
ARMK
$14.7B
$443K 0.02%
16,552
+670
+4% +$18.5K
FISV
697
Fiserv Inc
FISV
$27.9B
$442K 0.02%
5,961
-593
-9% -$43.1K
PPG icon
698
PPG Industries
PPG
$26.6B
$442K 0.02%
+4,266
New +$452K
REG icon
699
Regency Centers
REG
$14.1B
$441K 0.02%
+7,091
New +$416K
LKQ icon
700
LKQ Corp
LKQ
$6.29B
$440K 0.02%
+13,802
New +$460K

Similar funds

Vident Investment Advisory's Q2 2018 Portfolio in Review

As of Q2 2018, Vident Investment Advisory held 1,009 positions worth $2.53B, up 2.8% from $2.46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Vident Investment Advisory's Q2 2018 filing shows 121 new, 515 increased, 261 reduced and 111 closed positions. Its largest new stake was Arcus Biosciences: 156,139 shares worth $1.91M. The largest sale was Oceaneering, an estimated $17.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.

  • Vident Investment Advisory's largest Q2 2018 buy was Arcus Biosciences: 156,139 shares worth $1.91M.
  • Vident Investment Advisory added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $29.4M increase.
  • Vident Investment Advisory's biggest Q2 2018 reduction was Oceaneering, cutting an estimated $17.5M.
  • Vident Investment Advisory fully exited FIRST TRUST HIGH INCOME LONG/SHORT FUND in Q2 2018, selling an estimated $5.5M.
  • Vident Investment Advisory's ten largest holdings make up 16% of its $2.53B portfolio in Q2 2018.
  • Vident Investment Advisory opened 121 new positions and closed 111 in Q2 2018.
  • Vident Investment Advisory's portfolio value rose 2.8% quarter-over-quarter to $2.53B.

Based on Vident Investment Advisory's 13F filing for Q2 2018, filed 14 Aug 2018.